Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection

Salomón, 1992, Microcin 25, a novel antimicrobial peptide produced by, Escherichia coli. J Bacteriol, 174, 7428

Vincent, 2004, Inhibition of Salmonella enterica serovars by microcin J25, FEMS Microbiol Lett, 236, 103, 10.1111/j.1574-6968.2004.tb09634.x

Bayro, 2003, Structure of antibacterial peptide microcin J25: a 21-residue lariat protoknot, J Am Chem Soc, 125, 12382, 10.1021/ja036677e

Rosengren, 2003, Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone, J Am Chem Soc, 125, 12464, 10.1021/ja0367703

Wilson, 2003, Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail, J Am Chem Soc, 125, 12475, 10.1021/ja036756q

Rintoul, 2001, The antibacterial action of microcin J25: evidence for disruption of cytoplasmic membrane energization in Salmonella newport., FEMS Microbiol Lett, 204, 265, 10.1111/j.1574-6968.2001.tb10895.x

Miyazaki, 2004, Pharmacodynamics of S-3578, a novel cephem, in murine lung and systemic infection models, Antimicrob Agents Chemother, 48, 378, 10.1128/AAC.48.2.378-383.2004

Khan, 2001, Early responses to Salmonella typhimurium infection in mice occur at focal lesions in infected organs, Microb Pathog, 30, 29, 10.1006/mpat.2000.0405

Levy, 2001, Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis, Curr Infect Dis Rep, 3, 407, 10.1007/BF03160475

Gura, 2001, Innate immunity. Ancient system gets new respect, Science, 291, 2068, 10.1126/science.291.5511.2068

Levy, 2000, Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents, Blood, 96, 2664, 10.1182/blood.V96.8.2664

Chen, 2000, Development of protegrins for the treatment and prevention of oral mucositis: structure–activity relationships of synthetic protegrin analogues, Biopolymers, 55, 88, 10.1002/1097-0282(2000)55:1<88::AID-BIP80>3.0.CO;2-K

Ge, 1999, In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers, Diagn Microbiol Infect Dis, 35, 45, 10.1016/S0732-8893(99)00056-5

Jeu, 2004, Daptomycin: a cyclic lipopeptide antimicrobial agent, Clin Ther, 26, 1728, 10.1016/j.clinthera.2004.11.014

Craig, 1977, Protein binding of antimicrobials: clinical pharmacokinetics and therapeutic implications, Clin Pharmacokinet, 2, 252, 10.2165/00003088-197702040-00002

Dutcher, 1978, Potentiation of antibiotic activity by normal serum, Antimicrob Agents Chemother, 13, 820, 10.1128/AAC.13.5.820

Marca, 1973, Enhancement of the bacteriostatic and bactericidal activities of chloramphenicol and thiamphenicol by normal serum in vitro, Chemotherapy, 18, 91, 10.1159/000221250

Pruul, 1972, Interaction of complement and polymyxin with Gram-negative bacteria, Infect Immun, 6, 709, 10.1128/IAI.6.5.709-717.1972

Stratton, 1977, Serum dilution test for bactericidal activity. 1. Selection of a physiological diluent, J Infect Dis, 136, 187, 10.1093/infdis/136.2.187